Sleep is a vital function of the human body, and a lack of sleep can have serious implications on physical and mental health. For those who suffer from chronic insomnia, the search for a safe and effective sleep aid can be a frustrating one. Hydroxyzine, an antihistamine used to treat allergies and anxiety, is increasingly being used as an off-label treatment for insomnia. In this article, we will examine the potential benefits of hydroxyzine for sleep, as well as the optimal dosage for maximal effectiveness.
Hydroxyzine is an antihistamine used to treat symptoms of allergies and anxiety. It is available in both oral and injectable forms, and is sold under various brand names, including Atarax, Vistaril, and Anxanil. Hydroxyzine works by blocking histamine receptors, which helps to reduce inflammation and anxiety. It is also known to have sedative effects, which makes it an attractive option for those seeking relief from insomnia.
Hydroxyzine has been shown to be effective in treating insomnia in both short-term and long-term studies. In a double-blind, placebo-controlled study of patients with chronic insomnia, hydroxyzine was found to be more effective than a placebo in improving sleep quality and duration. In another study, hydroxyzine was found to be more effective than diphenhydramine, another antihistamine, in improving sleep quality and reducing daytime sleepiness. Hydroxyzine also has the advantage of being less likely to cause next-day drowsiness than other sleep aids. This is due to its long half-life, which means that it remains active in the body for a longer period of time. This makes it an attractive option for those who need to be able to function during the day.
The optimal dosage of hydroxyzine for sleep will vary depending on the individual. Generally, the recommended dosage is 25-50 mg taken at bedtime. However, some individuals may need higher doses, up to 100 mg per night. It is important to note that hydroxyzine should not be taken for more than two weeks at a time, as it can lead to tolerance and dependence.
Hydroxyzine is generally well-tolerated, but it can cause some side effects, including dry mouth, drowsiness, dizziness, and constipation. It can also interact with other medications, so it is important to discuss any potential interactions with your doctor before taking hydroxyzine.
Hydroxyzine is an effective and safe option for those looking for relief from insomnia. It is generally well-tolerated and less likely to cause next-day drowsiness than other sleep aids. The optimal dosage will vary depending on the individual, but is generally 25-50 mg taken at bedtime. It is important to speak to your doctor before taking hydroxyzine, as it can interact with other medications and can cause side effects.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation